- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 14, 2026 | 65.29M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 64.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 26.27M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $858.2K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $755.75K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $534.87K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $263.69K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$30.77M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$27.31M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $65.09M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $57.67M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $66.16M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $63.55M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $30.89M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $14.6M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $33.27M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $34.16M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.05 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.02 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $458.25K |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $677.96K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$3.41M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$403.1K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$799.2K |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.41M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $753.44K |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $1.54M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.17M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $2.77M |